Dimitrios Kirmizis

The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study

Gabor Cserep, David A. Morrow, Karen Latchford, Rachael Jesset et autres

gb, hu (code pays fourni par la source)

A call to optimize haemodialysis vascular access care in healthcare disrupted by COVID-19 pandemic

Carlo Basile, Carlo Lomonte, Christian Combe, Adrian Covic et autres

The COVID-19 pandemic has resulted in major disruption to the delivery of both routine and urgent healthcare needs in many institutions across the globe. Vascular access (VA) for haemodalysis (HD) is considered the patient's lifeline and its maintenance is essential for the …

it, fr, ro, gb, gr (code pays fourni par la source)

Μέτρα των ιδιωτικών Μονάδων Αιμοκάθαρσης για την αντιμετώπιση της πανδημίας COVID-19, Policies against the COVID-19 pandemic implemented by Greek privately owned Haemodialysis Units

Δ. Κιρμιζής, Λ. Γιονανλής, Ι. Δρούλιας, Ε. Ευθυμίου et autres

Errata

Francesco Gaetano Casino, Carlo Basile, Dimitrios Kirmizis, Mehmet Kanbay et autres

The reasons for a clinical trial on incremental haemodialysis, Nephrol Dial Transplant 2020; gfaa220. doi: 10.1093/ndt/gfaa220 In the originally published version of this article, there was an error in the spelling of author Loreto Gesualdo’s surname. This has now been corrected online.

Recent advances in treatment of haemodialysis

James O. Burton, Richard Corbett, Philip A. Kalra, Prashanth Vas et autres

Haemodialysis remains the most widely used treatment for patients with end-stage renal disease. Despite the progress that has occurred in the treatment of end-stage renal disease over the last six decades, there has been a failure to translate this into the desired …

gb (code pays fourni par la source)

Frontiers in hemodialysis: Innovations and technological advances

Carlo Basile, Andrew Davenport, Sandip Mitra, Avishek Pal et autres

As increasing demand for hemodialysis (HD) treatment incurs significant financial burden to healthcare systems and ecological burden as well, novel therapeutic approaches as well as innovations and technological advances are being sought that could lead to the development of purification devices such …

it, gb, nl (code pays fourni par la source)

The reasons for a clinical trial on incremental haemodialysis

Francesco Gaetano Casino, Carlo Basile, Dimitrios Kirmizis, Mehmet Kanbay et autres

An author video to accompany this article is available at https://academic.oup.com/ndt/pages/author_videos. There is growing interest in an incremental approach to haemodialysis (HD) for incident end-stage kidney disease (ESKD) patients, starting with one or two sessions per week [1–5]. Such an approach not …

it, gb, tr, nl, at (code pays fourni par la source)

Coronary artery disease in dialysis patients: evidence synthesis, controversies and proposed management strategies

Alexandru Burlacu, Simonetta Genovesi, Carlo Basile, Alberto Ortíz et autres

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality among patients with end-stage renal disease (ESRD). Clustering of traditional atherosclerotic and non-traditional risk factors drive the excess rates of coronary and non-coronary CVD in this population. The incidence, severity and …

ro, it, es, gb, tr, nl (code pays fourni par la source)

Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres

Carlo Basile, Christian Combe, Francesco Pizzarelli, Adrian Covic et autres

COVID-19, a disease caused by a novel coronavirus, is a major global human threat that has turned into a pandemic. This novel coronavirus has specifically high morbidity in the elderly and in comorbid populations. Uraemic patients on dialysis combine an intrinsic fragility …

it, fr, ro, gb, tr, at, nl (code pays fourni par la source)

Calcium balance in hemodialysis: More uncertainty than certainty

Dimitrios Kirmizis, Carlo Basile

There is controversy about the choice of dialysate calcium concentration (DCa), with strong arguments both in favor of and against the use of a low or high DCa, as they can both be potentially harmful. Evidence suggests that calcium mass balance is …

gb, it (code pays fourni par la source)

Sudden cardiac death in dialysis patients: different causes and management strategies

Simonetta Genovesi, Giuseppe Boriani, Adrian Covic, Robin W.M. Vernooij et autres

Sudden cardiac death (SCD) represents a major cause of death in end-stage kidney disease (ESKD). The precise estimate of its incidence is difficult to establish because studies on the incidence of SCD in ESKD are often combined with those related to sudden …

it, ro, nl, fr, gb, tr, at (code pays fourni par la source)

Exit-Site Relocation: A Novel, Straightforward Technique for Exit-Site Infections

Dimitrios Kirmizis, Elaine Bowes, Behzad Ansari, Hugh Cairns

Background Exit-site infection (ESI) and tunnel infection (TI) of the peritoneal dialysis (PD) catheter are significant causes of catheter or even method loss as well as patient morbidity. Among the methods that have been in use thus far, the removal and replacement …

gb (code pays fourni par la source)